Whether stemming from early childhood adversity, combat exposure, or interpersonal abuse, trauma leaves long-term imprints on ...

Improving efficiencies and uncomplicating processes are critical to the future success of NHS Trusts across the country. The ...

Taiho Pharmaceutical has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy ...

Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...

The second annual HLTH Europe conference brought together health leaders, start-ups, investors, and developers from across the globe for a mid-year pulse check on where healthcare innovation stands ...

A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young ...

South Korean electronics giant Samsung has continued a push into the health category with an agreement to buy Xealth, a ...

Medistry LLC is the internet registry operator of the .med top level domain (TLD). Currently in a period of pre-registration ...

Discover the most exciting and informative pharma events happening around the world during March, April and 2024. Stay up-to-date with the industry, network with professionals, and gain insights ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery ...

Biogen says it is the first drugmaker in the US to get FDA approval for a biosimilar of Roche’s $3 billion blockbuster product Actemra. The intravenous biosimilar of IL-6 inhibi ...

Like many industries, the pharmaceutical labour market has felt and will continue to feel the impacts of the COVID-19 pandemic moving into 2023 and beyond. A new operating model for pharma shifted ...